NG2+ oligodendrocyte progenitor cells (OPCs) represent a metabolically distinct oligodendrocyte lineage population with high baseline glycolytic activity and sensitivity to mitochondrial dysfunction, serving as critical metabolic sensors of white matter integrity in the CNS. This hypothesis proposes that OPCs possess unique metabolic checkpoint mechanisms (analogous to the AMPK-mTORC1 metabolic checkpoint in other stem cell populations) that govern the decision between self-renewal and differentiation, and that failure of these checkpoints during aging drives OPC senescence, impaired remyelination capacity, and accelerated white matter degeneration in AD, PD, and ALS. Specifically, OPCs depend on a metabolic checkpoint governed by AMPK-mediated phosphorylation of TSC2 (activating Rheb GTPase inhibition) and direct phosphorylation of raptor (disabling mTORC1 activity), which together create a metabolic brake that permits the cellular remodeling required for differentiation.
...Curated pathway from expert analysis
flowchart TD
A["Age-Related NAD+ Decline<br/>White Matter OPCs Vulnerable"]
B["SIRT1 Activity Decreases<br/>p53 Hyperacetylation"]
C["p53 Transcriptionally Activates<br/>p21CIP1 and p16INK4a in OPCs"]
D["AMPK-TSC2 Metabolic Checkpoint Failure<br/>AMPK Activity Down 45 percent"]
E["mTORC1 Hyperactivation<br/>Differentiation Brake Overridden"]
F["OPC Senescence<br/>Self-Renewal vs Differentiation Imbalance"]
G["Impaired Remyelination<br/>White Matter Corpus Callosum Degeneration"]
H["AICAR AMPK Activator via AAV-Olig001<br/>OPC-Specific Metabolic Rescue Target"]
A --> B
B --> C
A --> D
C --> F
D --> E
E --> F
F --> G
H -.->|"restores checkpoint"| D
style F fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style H fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for NG2 yet. Search RCSB →
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NG2,AMPK,PRKAA1,TSC2,MTOR,RPTOR,SIRT1,CDKN2A,MBP,PLP1,OLIG1,OLIG2.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 6-month-old 5xFAD mice receive intra-cerebral AAV-Olig001-mediated expression of a constitutively active AMPKα1 (PRKAA1-S485D) or daily intraperitoneal TLM (30 mg/kg) for 8 weeks, THEN corpus callo | Increased MBP+ area fraction (≥35% relative increase) and improved g-ratio (≤0.70 mean) in the corpus callosum at 8 weeks post-intervention. | — no observation — | pending | 0.72 |
| IF 18-month-old C57BL/6J mice receive oral nicotinamide riboside (NR, 400 mg/kg/day) or NMN (300 mg/kg/day) supplementation for 12 weeks, THEN flow cytometry-isolated NG2+ OPCs from the corpus callosu | ≥50% decrease in p16INK4a expression, ≥40% reduction in SA-β-gal+ cells, and ≥30% increase in differentiation markers in NG2+ OPCs. | — no observation — | pending | 0.64 |